Your browser doesn't support javascript.
loading
Ecdysteroids sensitize MDR and non-MDR cancer cell lines to doxorubicin, paclitaxel, and vincristine but tend to protect them from cisplatin.
Martins, Ana; Sipos, Péter; Dér, Katalin; Csábi, József; Miklos, Walter; Berger, Walter; Zalatnai, Attila; Amaral, Leonard; Molnár, Joseph; Szabó-Révész, Piroska; Hunyadi, Attila.
Afiliación
  • Martins A; Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, Szeged 6720, Hungary ; Unidade de Parasitologia e Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008 Lisbon, Portugal.
  • Sipos P; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Szeged, Eötvös Ucta 6, Szeged 6720, Hungary.
  • Dér K; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Szeged, Eötvös Ucta 6, Szeged 6720, Hungary.
  • Csábi J; Institute of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Eötvös Ucta 6, Szeged 6720, Hungary.
  • Miklos W; Department of Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8A, 1090 Vienna, Austria.
  • Berger W; Department of Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Borschkegasse 8A, 1090 Vienna, Austria ; Institute of Inorganic Chemistry and Research Platform "Translational Cancer Therapy Research", University of Vienna, Waehringer Strasse 42,
  • Zalatnai A; First Department of Pathology and Experimental Cancer Research, Semmelweis University, Ülloi út 26, Budapest 1085, Hungary.
  • Amaral L; Centro de Malária e Outras Doenças Tropicais (CMDT), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008 Lisbon, Portugal.
  • Molnár J; Department of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, Szeged 6720, Hungary.
  • Szabó-Révész P; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Szeged, Eötvös Ucta 6, Szeged 6720, Hungary.
  • Hunyadi A; Institute of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Eötvös Ucta 6, Szeged 6720, Hungary.
Biomed Res Int ; 2015: 895360, 2015.
Article en En | MEDLINE | ID: mdl-26075272
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Cisplatino / Paclitaxel / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Ecdisteroides / Neoplasias Límite: Animals / Humans Idioma: En Revista: Biomed Res Int Año: 2015 Tipo del documento: Article País de afiliación: Portugal
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Cisplatino / Paclitaxel / Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Ecdisteroides / Neoplasias Límite: Animals / Humans Idioma: En Revista: Biomed Res Int Año: 2015 Tipo del documento: Article País de afiliación: Portugal